Partner Content Partner Content Improving Access to Innovative Paediatric Medicines Paediatric Clinical Trials
News FDA approves Valeant eye drug after manufacturing delay Regulator backs potential blockbuster ophthalmology drug
News FDA takes big step towards manufacturing harmonisation with ... FDA agrees to recognise some EU inspections for the first time
News Merck & Co pulls Keytruda lung cancer filing in Europe Blow for Merck as Keytruda sales top $1 billion per quarter.
News uniQure presses 'refresh' on haemophilia gene therapy, gets ... Biotech has been in talks with US and EU regulators
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
